Tag Archives: moderna

As the search for COVID-19 vaccines intensifies, there are at least 20 coronavirus vaccines in the pipeline. However, Gilead Sciences (GILD) and Moderna (MRNA), the stocks of the leaders in the race, tumbled as the week came to the end.Coronavirus alias COVID-19 is the virus that has taken the humankind hostage for the past two months. It has led to most biotech companies to push beyond their limits in the search for a vaccine. As a result, the World Health Organization (WHO) officials...

Moderna (MRNA) stock tanked by 10.48% on Thursday. The slide followed FDA Stephen Huhn’s statement that the COVID-19 vaccine is at least a year away.After a short upward, Moderna Inc (NASDAQ: MRNA) stock has plunged. Yesterday, it closed at $28.27, 10.48% down from the previous mark. Before, Moderna stock had a sweet period, albeit short, accompanied by the positive coronavirus news.Moderna (MRNA) Stock PriceOn March 16, the biotech company dosed the first patient in a study of its...

Avigan, also known as Favipiravir, is a Japanese flu drug developed by the healthcare arm of Fujifilm. 340 patients taking the drug found it reduces recovery time and improves their lung condition. Enthralled by COVID-19, the world is waiting for a hero who will find the coronavirus vaccine. And one of the most widely-discussed variants to treat coronavirus today is Favipiravir (or Avigan). Worldwide famous biotech companies such as Gilead Sciences Inc (NASDAQ: GILD), Inovio Pharmaceuticals...

Let’s have a closer look at Gilead Sciences Inc (NASDAQ: GILD) and Moderna Inc (NASDAQ: MRNA) stocks as the companies are working on possible coronavirus vaccine.In the race for a coronavirus vaccine, two horses battle for the lead, Gilead Sciences Inc (NASDAQ: GILD) and Moderna Inc (NASDAQ: MRNA). As a result, a lot of speculation on the booming of their stock prices has been in the mainstream media, since the outbreak of the deadly virus.Gilead Sciences is an American public biotech company...

Initiating human trials is only one step in the long process of proving the safety and efficacy of a new therapeutic. Still, the timeframes to beginning testing for Moderna, BioNTech and CureVac are faster than typical for traditional vaccines.We already wrote how almost all pharmaceutical firms throughout the whole world are doing everything to develop a vaccine that would help to stop the coronavirus spread. No matter if they’re big or small, the goal is the same and it is no more just a...

Moderna (MRNA) stock rocketed today after the biotech company dosed the first patient in a study of its coronavirus vaccine. The drug aims to use a natural function called messenger RNA to protect against the SARS-CoV-2 virus that causes Covid-19.American pharmaceutical company Moderna Inc (NASDAQ: MRNA) stock started rising yesterday and kept their pace today as well. Yesterday, the MRNA price jumped over 24%. Today Moderna stock continued moving higher. The stock has managed to jump another...

Gilead Sciences (GILD) stock price has moved up at the news that its drug remdesivir is used to treat coronavirus patients on ‘compassionate’ grounds.Gilead Sciences Inc (NASDAQ: GILD) stock has made some gains after the confirmation of the use of one of its drugs on U.S. soil. Sources say that Remdesivir is being used to treat several patients who have coronavirus. The drug is not approved by the U.S. Food and Drug Administration (FDA). Certain rules allow for the use of such mediations on...

Some new evergreen stocks could become a new choice for investors. Moderna (MRNA), Gilead Sciences (GILD) and Co-Diagnostics (CODX) are also expected to change the game for coronavirus.New evergreen stocks could emerge as a result of the coronavirus crisis. These stocks have won such a status as global markets have tanked following the outbreak of COVID-19. The gaps created by coronavirus has caused the global economy to come to a standstill. This has affected the businesses all over the...

Inovio(INO) stock is enjoying the rally as it put on almost 8% weight days after it announced that it will be speeding up plans for its coronavirus (COVID-19) vaccine.There are a few biotech companies currently working on treating the new coronavirus COVID-19 strain. For these companies right now, nothing is more important than giving the world a solution to either treat or prevent new cases of the virus, via a vaccine. While there is considerable progress being made by these firms, Inovio...

Moderna (MRNA) stock has fallen since the last week’s announcement of a possible vaccine for COVID-19. Its CEO has indicated that the prices for the coronavirus vaccine will be affordable.Moderna Inc (NASDAQ: MRNA) stock remained low. It lost 1.5% yesterday and today in the premarket it is nearly 4% down. This comes as the CEO of the biotech startup has indicated that the company’s COVID-19 vaccine will be affordable. Sources report that Stephane Bancel said that the price will be within the...